In chapter four, “Larger Landscape Trends,” of my book Get to Market Now!, I analyze the impact of the pre-informed patient, and the challenges drug and device firms increasingly face in the 21st century.
This year, in an October 5th Federal Register notice, FDA stated that it will conduct at least two national surveys to “assess behaviors and beliefs related to the use of medical products.” In other words, the FDA recognizes that drug and device executives need to start incorporating the voice of the customer from … Continue reading at ComplianceZen.com →